THE AGILVAX VLP PLATFORM

Cloned Genes

1. Cloned genes: library or specific antigens + VLP

Bacterial Based Manufacturing

2. Bacterial based manufacturing

VLP Candidate

3. VLP vaccine candidate


Agilvax’s immunotherapy and vaccine discovery and development platform ensures high immunogenicity to both foreign and self-antigens.

Agilvax Propriety VLP Platform Highlights